Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

CMIC HOLDINGS

OTCPK:CMIC.F
Snowflake Description

Excellent balance sheet and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
CMIC.F
OTCPK
¥23B
Market Cap
  1. Home
  2. US
  3. Pharmaceuticals & Biotech
Company description

CMIC HOLDINGS Co., Ltd. provides various services for the pharmaceutical industry in Japan. The last earnings update was 54 days ago. More info.


Add to Portfolio Compare Print
CMIC.F Share Price and Events
7 Day Returns
0%
OTCPK:CMIC.F
1.4%
US Life Sciences
-2%
US Market
1 Year Returns
-
OTCPK:CMIC.F
-8.1%
US Life Sciences
-15.1%
US Market
CMIC.F Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
CMIC HOLDINGS (CMIC.F) 0% -13.4% - - - -18.8%
US Life Sciences 1.4% -14.5% -16.3% -8.1% 58.1% 77.8%
US Market -2% -19.7% -23.2% -15.1% 3.7% 14.4%
1 Year Return vs Industry and Market
  • No trading data on CMIC.F.
  • No trading data on CMIC.F.
Price Volatility
CMIC.F
Industry
5yr Volatility vs Market

Value

 Is CMIC HOLDINGS undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of CMIC HOLDINGS to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for CMIC HOLDINGS.

OTCPK:CMIC.F Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 1 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 10.9%
Perpetual Growth Rate 10-Year US Government Bond Rate 1.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for OTCPK:CMIC.F
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 1.7%
Equity Risk Premium S&P Global 6.3%
Life Sciences Unlevered Beta Simply Wall St/ S&P Global 1.03
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.03 (1 + (1- 30.86%) (88.24%))
1.441
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.44
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.74% + (1.441 * 6.33%)
10.86%

Discounted Cash Flow Calculation for OTCPK:CMIC.F using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for CMIC HOLDINGS is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

OTCPK:CMIC.F DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (JPY, Millions) Source Present Value
Discounted (@ 10.86%)
2020 2,488.00 Analyst x1 2,244.20
2021 2,234.00 Analyst x1 1,817.63
2022 2,075.00 Analyst x1 1,522.83
2023 2,125.00 Analyst x1 1,406.71
2024 2,081.00 Analyst x1 1,242.60
2025 2,063.88 Est @ -0.82% 1,111.62
2026 2,062.78 Est @ -0.05% 1,002.15
2027 2,072.77 Est @ 0.48% 908.33
2028 2,090.62 Est @ 0.86% 826.38
2029 2,114.13 Est @ 1.12% 753.78
Present value of next 10 years cash flows ¥12,836.00
OTCPK:CMIC.F DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= ¥2,114.13 × (1 + 1.74%) ÷ (10.86% – 1.74%)
¥23,575.66
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= ¥23,575.66 ÷ (1 + 10.86%)10
¥8,405.81
OTCPK:CMIC.F Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= ¥12,836.00 + ¥8,405.81
¥21,241.81
Equity Value per Share
(JPY)
= Total value / Shares Outstanding
= ¥21,241.81 / 18.07
¥1175.38
OTCPK:CMIC.F Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in OTCPK:CMIC.F represents 0.01002x of TSE:2309
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.01002x
Value per Share
(Listing Adjusted, USD)
= Value per Share (JPY) x Listing Adjustment Factor
= ¥ 1,175.38 x 0.01002
$11.77
Value per share (USD) From above. $11.77
Current discount Discount to share price of $12.65
= -1 x ($12.65 - $11.77) / $11.77
-7.5%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of CMIC HOLDINGS is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for CMIC HOLDINGS's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are CMIC HOLDINGS's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:CMIC.F PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in JPY ¥96.58
TSE:2309 Share Price ** TSE (2020-03-25) in JPY ¥1263
United States of America Life Sciences Industry PE Ratio Median Figure of 19 Publicly-Listed Life Sciences Companies 27.63x
United States of America Market PE Ratio Median Figure of 2,947 Publicly-Listed Companies 12.4x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of CMIC HOLDINGS.

OTCPK:CMIC.F PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSE:2309 Share Price ÷ EPS (both in JPY)

= 1263 ÷ 96.58

13.08x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • CMIC HOLDINGS is good value based on earnings compared to the US Life Sciences industry average.
  • CMIC HOLDINGS is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does CMIC HOLDINGS's expected growth come at a high price?
Raw Data
OTCPK:CMIC.F PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 13.08x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
13.2%per year
United States of America Life Sciences Industry PEG Ratio Median Figure of 16 Publicly-Listed Life Sciences Companies 2.13x
United States of America Market PEG Ratio Median Figure of 2,010 Publicly-Listed Companies 0.89x

*Line of best fit is calculated by linear regression .

OTCPK:CMIC.F PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 13.08x ÷ 13.2%

0.99x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • CMIC HOLDINGS is good value based on expected growth next year.
Price based on value of assets
What value do investors place on CMIC HOLDINGS's assets?
Raw Data
OTCPK:CMIC.F PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in JPY ¥1,226.58
TSE:2309 Share Price * TSE (2020-03-25) in JPY ¥1263
United States of America Life Sciences Industry PB Ratio Median Figure of 38 Publicly-Listed Life Sciences Companies 4.29x
United States of America Market PB Ratio Median Figure of 5,144 Publicly-Listed Companies 1.2x
OTCPK:CMIC.F PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSE:2309 Share Price ÷ Book Value per Share (both in JPY)

= 1263 ÷ 1,226.58

1.03x

* Primary Listing of CMIC HOLDINGS.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • CMIC HOLDINGS is good value based on assets compared to the US Life Sciences industry average.
X
Value checks
We assess CMIC HOLDINGS's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Life Sciences industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Life Sciences industry average (and greater than 0)? (1 check)
  5. CMIC HOLDINGS has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is CMIC HOLDINGS expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
13.2%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is CMIC HOLDINGS expected to grow at an attractive rate?
  • CMIC HOLDINGS's earnings growth is expected to exceed the low risk savings rate of 1.7%.
Growth vs Market Checks
  • CMIC HOLDINGS's earnings growth is positive but not above the United States of America market average.
  • CMIC HOLDINGS's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
Raw Data
OTCPK:CMIC.F Future Growth Rates Data Sources
Data Point Source Value (per year)
OTCPK:CMIC.F Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts 13.2%
OTCPK:CMIC.F Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 3.9%
United States of America Life Sciences Industry Earnings Growth Rate Market Cap Weighted Average 17%
United States of America Life Sciences Industry Revenue Growth Rate Market Cap Weighted Average 6.6%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.4%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:CMIC.F Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in JPY Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:CMIC.F Future Estimates Data
Date (Data in JPY Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2024-09-30
2023-09-30
2022-09-30 85,800 4,975 2,600 1
2021-09-30 83,400 5,084 2,300 1
2020-09-30 80,500 5,338 2,100 1
2020-04-04
OTCPK:CMIC.F Past Financials Data
Date (Data in JPY Millions) Revenue Cash Flow Net Income *
2019-12-31 76,774 1,767
2019-09-30 74,373 4,922 1,822
2019-06-30 73,100 2,167
2019-03-31 72,862 7,246 2,534
2018-12-31 70,631 1,479
2018-09-30 69,869 7,488 1,487
2018-06-30 68,928 1,754
2018-03-31 67,179 5,666 1,506
2017-12-31 66,530 1,894
2017-09-30 65,282 4,937 1,550
2017-06-30 63,781 1,037
2017-03-31 63,015 5,762 582

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • CMIC HOLDINGS's earnings are expected to grow by 13.2% yearly, however this is not considered high growth (20% yearly).
  • CMIC HOLDINGS's revenue is expected to grow by 3.9% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:CMIC.F Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from CMIC HOLDINGS Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:CMIC.F Future Estimates Data
Date (Data in JPY Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2024-09-30
2023-09-30
2022-09-30 143.90 143.90 143.90 1.00
2021-09-30 127.30 127.30 127.30 1.00
2020-09-30 116.20 116.20 116.20 1.00
2020-04-04
OTCPK:CMIC.F Past Financials Data
Date (Data in JPY Millions) EPS *
2019-12-31 96.58
2019-09-30 98.91
2019-06-30 116.89
2019-03-31 136.28
2018-12-31 79.40
2018-09-30 79.68
2018-06-30 93.81
2018-03-31 80.50
2017-12-31 101.25
2017-09-30 82.87
2017-06-30 55.45
2017-03-31 31.12

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • CMIC HOLDINGS is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess CMIC HOLDINGS's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
CMIC HOLDINGS has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has CMIC HOLDINGS performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare CMIC HOLDINGS's growth in the last year to its industry (Life Sciences).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • CMIC HOLDINGS has delivered over 20% year on year earnings growth in the past 5 years.
  • CMIC HOLDINGS's 1-year earnings growth is less than its 5-year average (19.5% vs 38.3%)
  • CMIC HOLDINGS's earnings growth has not exceeded the US Life Sciences industry average in the past year (19.5% vs 21.5%).
Earnings and Revenue History
CMIC HOLDINGS's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from CMIC HOLDINGS Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:CMIC.F Past Revenue, Cash Flow and Net Income Data
Date (Data in JPY Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 76,774.00 1,767.00 12,103.00
2019-09-30 74,373.00 1,822.00 11,706.00
2019-06-30 73,100.00 2,167.00 11,376.00
2019-03-31 72,862.00 2,534.00 11,032.00
2018-12-31 70,631.00 1,479.00 10,768.00
2018-09-30 69,869.00 1,487.00 10,570.00
2018-06-30 68,928.00 1,754.00 10,375.00
2018-03-31 67,179.00 1,506.00 10,366.00
2017-12-31 66,530.00 1,894.00 10,431.00
2017-09-30 65,282.00 1,550.00 10,340.00
2017-06-30 63,781.00 1,037.00 10,082.00
2017-03-31 63,015.00 582.00 9,938.00
2016-12-31 62,795.00 874.00 9,751.00
2016-09-30 62,039.00 878.00 9,733.00
2016-06-30 61,332.00 749.00 9,866.00
2016-03-31 60,160.00 174.00 10,019.00
2015-12-31 57,474.00 -569.00 9,787.00
2015-09-30 55,904.00 -542.00 9,676.00
2015-06-30 54,839.00 -468.00 9,290.00
2015-03-31 53,841.00 542.00 8,724.00
2014-12-31 52,801.00 1,034.00 8,504.00
2014-09-30 52,836.00 1,174.00 8,120.00
2014-06-30 51,904.00 1,567.00 7,992.00
2014-03-31 51,231.00 1,165.00 8,039.00
2013-12-31 51,176.00 1,450.00 8,007.00
2013-09-30 50,934.00 1,753.00 7,985.00
2013-06-30 50,889.00 1,724.00 7,936.00

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • CMIC HOLDINGS has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • CMIC HOLDINGS used its assets less efficiently than the US Life Sciences industry average last year based on Return on Assets.
  • CMIC HOLDINGS's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess CMIC HOLDINGS's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Life Sciences industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
CMIC HOLDINGS has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is CMIC HOLDINGS's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up CMIC HOLDINGS's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • CMIC HOLDINGS is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • CMIC HOLDINGS's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of CMIC HOLDINGS's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.8x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from CMIC HOLDINGS Company Filings, last reported 3 months ago.

OTCPK:CMIC.F Past Debt and Equity Data
Date (Data in JPY Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 32,924.00 20,140.00 10,938.00
2019-09-30 32,993.00 19,196.00 12,146.00
2019-06-30 33,639.00 20,715.00 12,789.00
2019-03-31 33,891.00 20,706.00 14,939.00
2018-12-31 32,673.00 22,831.00 15,441.00
2018-09-30 33,535.00 19,276.00 14,009.00
2018-06-30 24,406.00 22,845.00 5,142.00
2018-03-31 24,392.00 22,348.00 5,483.00
2017-12-31 23,837.00 21,976.00 6,209.00
2017-09-30 23,607.00 18,898.00 4,947.00
2017-06-30 23,118.00 21,489.00 5,892.00
2017-03-31 22,297.00 19,751.00 5,747.00
2016-12-31 21,699.00 20,456.00 5,590.00
2016-09-30 21,397.00 16,085.00 5,069.00
2016-06-30 21,477.00 18,742.00 7,448.00
2016-03-31 21,484.00 19,684.00 7,052.00
2015-12-31 20,897.00 19,746.00 5,899.00
2015-09-30 20,667.00 18,069.00 5,804.00
2015-06-30 21,156.00 19,898.00 5,558.00
2015-03-31 21,851.00 17,761.00 5,497.00
2014-12-31 20,551.00 14,825.00 5,107.00
2014-09-30 20,309.00 13,409.00 5,922.00
2014-06-30 20,300.00 12,558.00 6,276.00
2014-03-31 20,142.00 12,091.00 8,659.00
2013-12-31 19,793.00 10,990.00 6,565.00
2013-09-30 19,602.00 9,424.00 6,962.00
2013-06-30 19,444.00 9,623.00 7,023.00
  • CMIC HOLDINGS's level of debt (61.2%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (72.2% vs 61.2% today).
  • Debt is well covered by operating cash flow (24.4%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 40.4x coverage).
X
Financial health checks
We assess CMIC HOLDINGS's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. CMIC HOLDINGS has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is CMIC HOLDINGS's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
2.53%
Current annual income from CMIC HOLDINGS dividends. Estimated to be 3.17% next year.
If you bought $2,000 of CMIC HOLDINGS shares you are expected to receive $51 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • CMIC HOLDINGS's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (2.05%).
  • CMIC HOLDINGS's dividend is below the markets top 25% of dividend payers in United States of America (5.71%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:CMIC.F Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
United States of America Life Sciences Industry Average Dividend Yield Market Cap Weighted Average of 8 Stocks 0.4%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1938 Stocks 3.1%
United States of America Minimum Threshold Dividend Yield 10th Percentile 1.1%
United States of America Bottom 25% Dividend Yield 25th Percentile 2.1%
United States of America Top 25% Dividend Yield 75th Percentile 5.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

OTCPK:CMIC.F Future Dividends Estimate Data
Date (Data in ¥) Dividend per Share (annual) Avg. No. Analysts
2024-09-30
2023-09-30
2022-09-30 42.00 1.00
2021-09-30 40.00 1.00
2020-09-30 38.00 1.00
2020-04-04
OTCPK:CMIC.F Past Annualized Dividends Data
Date (Data in ¥) Dividend per share (annual) Avg. Yield (%)
2018-12-14 32.000 1.855
2018-11-07 32.000 1.538
2018-04-27 27.500 1.197
2018-02-01 27.500 1.042
2017-12-15 27.500 1.358
2017-11-07 27.500 1.622
2017-07-28 19.000 1.223
2017-05-10 19.000 1.295
2017-04-28 19.000 1.320
2016-12-15 19.000 1.295
2016-11-07 19.000 1.303
2016-08-10 10.000 0.667
2016-07-29 16.000 1.061
2016-05-12 10.000 0.621
2016-04-28 16.000 0.980
2015-12-16 10.000 0.688
2015-11-05 10.000 0.608
2015-08-06 35.000 2.131
2015-07-31 35.000 2.042
2015-05-11 35.000 2.089
2015-04-30 35.000 2.061
2014-12-17 35.000 1.873
2014-11-05 35.000 2.131
2014-08-06 35.000 1.877
2014-07-31 35.000 1.791
2014-05-09 35.000 2.155
2014-04-30 35.000 2.337
2013-12-13 35.000 2.480
2013-11-06 35.000 2.911
2012-12-14 35.000 2.174
2012-11-07 35.000 2.967
2012-08-03 31.000 2.506
2012-05-07 31.000 2.550
2012-02-06 31.000 2.449
2011-12-15 31.000 2.601
2011-11-07 31.000 2.469
2011-08-05 26.500 1.962
2011-05-06 26.500 1.966
2011-02-14 26.500 1.990
2011-02-07 26.500 2.055
2010-12-15 26.500 2.285
2010-11-09 26.500 2.306
2010-08-13 19.000 1.495
2010-08-06 19.000 1.522
2010-05-14 19.000 1.522
2010-05-07 19.000 1.505
2010-02-05 19.000 1.806
2009-12-15 19.000 2.042
2009-11-06 19.000 1.957
2009-08-14 16.700 1.417
2009-05-15 16.700 1.547

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of CMIC HOLDINGS's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (3x coverage).
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess CMIC HOLDINGS's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can CMIC HOLDINGS afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. CMIC HOLDINGS has a total score of 3/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of CMIC HOLDINGS's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Kazuo Nakamura
AGE 73
TENURE AS CEO 16.5 years
CEO Bio

Dr. Kazuo Nakamura, Ph.D., has been the Chairman and Chief Executive Officer of CMIC HOLDINGS Co., Ltd. since October 2003 and had been its President and is Director since March 1992. Dr. Nakamura is also serves as Head of Strategy Planning Unit at CMIC HOLDINGS Co., Ltd. Dr. Nakamura has been Chairman of the Board of Directors at CMIC (Beijing) Co., Ltd since July 2004. He was employed at Daiichi Sankyo Co., Ltd. until January 1992. He serves as a Director of Perseus Proteomics Inc. Dr. Nakamuara earned his bachelor’s degree from Faculty of Pharmaceutical Sciences, Kyoto University and doctoral degree from Graduate School of Natural Science & Technology, Kanazawa University.

CEO Compensation
  • Insufficient data for Kazuo to compare compensation growth.
  • Insufficient data for Kazuo to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the CMIC HOLDINGS management team in years:

8.3
Average Tenure
62
Average Age
  • The average tenure for the CMIC HOLDINGS management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Kazuo Nakamura

TITLE
Founder
AGE
73
TENURE
16.5 yrs

Yoichi Kuwajima

TITLE
Vice Chairman & Division Head of Strategy Management Division
AGE
62
TENURE
1 yrs

Keiko Oishi

TITLE
President
AGE
62
TENURE
2 yrs

Wataru Mochizuki

TITLE
CFO, Executive VP
AGE
58
TENURE
2.3 yrs

Takeshi Hamaura

TITLE
CTO, Executive VP & Director

Yoshiyuki Hano

TITLE
Exe. VP
TENURE
8.3 yrs

Hisao Matsubara

TITLE
Senior VP
AGE
54
TENURE
8.3 yrs

Takashi Sano

TITLE
Exe. VP
AGE
72
TENURE
11.3 yrs

Makoto Matsukawa

TITLE
Executive VP
AGE
59

Philippe Auvaro

TITLE
Executive Vice President
Board of Directors Tenure

Average tenure and age of the CMIC HOLDINGS board of directors in years:

3.3
Average Tenure
62
Average Age
  • The tenure for the CMIC HOLDINGS board of directors is about average.
Board of Directors

Kazuo Nakamura

TITLE
Founder
AGE
73
TENURE
16.5 yrs

Yoichi Kuwajima

TITLE
Vice Chairman & Division Head of Strategy Management Division
AGE
62
TENURE
1 yrs

Keiko Oishi

TITLE
President
AGE
62

Wataru Mochizuki

TITLE
CFO, Executive VP
AGE
58
TENURE
2.3 yrs

Takeshi Hamaura

TITLE
CTO, Executive VP & Director

Yoshiyuki Hano

TITLE
Exe. VP

Makoto Matsukawa

TITLE
Executive VP
AGE
59
TENURE
2.3 yrs

Philippe Auvaro

TITLE
Executive Vice President
TENURE
4.3 yrs

Toru Fujieda

TITLE
Executive VP

Akira Nakamuara

TITLE
External Corporate Director
AGE
75
TENURE
5.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess CMIC HOLDINGS's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. CMIC HOLDINGS has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

CMIC HOLDINGS Co., Ltd. provides various services for the pharmaceutical industry in Japan. The company operates in five segments: Contract Research Organization, Contract Development and Manufacturing Organization, Contract Sales Organization (CSO), Healthcare, and Innovative Pharma Model. It offers non-clinical research, CMC and GMP analytical, bioanalysis, biopharmaceuticals, quality assurance/non-clinical safety tests for regenerative medicine, quality testing for high pharmacological active APIs and products, inspection/accreditation, GMP solution, and laboratory services. The company also provides monitoring, data management, eClinical trials, STAT analysis, registration, quality management and assurance, pharmacovigilance, in-country clinical caretaker, specified worker dispatching in clinical development, and site management organization services, as well as Forum PLUS, a peer live update solution for clinical trials system. In addition, it offers strategic and regulatory affairs consulting, and medical writing services; supporting implementation of risk management plan, early post-marketing phase vigilance, supporting drug use-results survey/pharmacoepidemiological study, supporting re-examination request, safety information management, dispatching/contracting in post-marketing surveillance, and budget management services. Further, the company is involved in the contract manufacturing of drugs; and provision of pharmaceutical development support, investigational medicinal product manufacturing, and consultation services, as well as CSO, contact center, and medical affairs solutions. Additionally, it offers e-solutions, recruitment and staffing services, L-type fatty acid binding protein, supporting clinical research, medical and detailing call center, patient recruitment service, Web patient community, and patient support programs; and develops and markets orphan drugs and diagnostics. The company was founded in 1985 and is headquartered in Tokyo, Japan.

Details
Name: CMIC HOLDINGS Co., Ltd.
CMIC.F
Exchange: OTCPK
Founded: 1985
¥210,349,588
18,072,244
Website: http://www.cmicgroup.com
Address: CMIC HOLDINGS Co., Ltd.
Hamamatsucho Building,
1-1-1 Shibaura,
Tokyo,
105-0023,
Japan
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSE 2309 Common Stock The Tokyo Stock Exchange JP JPY 17. Jun 2002
OTCPK CMIC.F Common Stock Pink Sheets LLC US USD 17. Jun 2002
Number of employees
Current staff
Staff numbers
5,344
CMIC HOLDINGS employees.
Industry
Life Sciences Tools and Services
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/04 08:16
End of day share price update: 2020/03/25 00:00
Last estimates confirmation: 2020/02/04
Last earnings filing: 2020/02/10
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/09/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.